Members' Corner

Go to:

Welcome to our Members' Corner. Here you will find the latest news and best practices from our members, useful resources, training opportunities and ways to support the global cancer community. 


Member news

2022 World Cancer Congress UICC Regional meetings

Regional Meetings.jpg

More than 200 cancer control professionals attended the Regional meetings organised during the 2022 World Cancer Congress on October 18-20. UICC members and the cancer community had the chance to connect and share experiences on the theme of equity and Universal Health Coverage (UHC). These meetings offered the opportunity to explore further collaborations according to the specific needs of each one of the six UICC regions.

Raising breast cancer awareness in difficult settings: an example from the Afghanistan NCD Alliance

Breast Cancer Afghanistan

October is Breast Cancer Awareness Month and UICC member organisation Afghanistan NCD Alliance, in collaboration with the National Cancer Control Program (NCCP) of the Ministry of Public Health and the Afghanistan Society of Obstetrician and Gynaecologists (AFSOG), conducted 5 campaigns to raise awareness about breast cancer and cervical cancer as it is currently the most common cancer in Afghan women. The campaigns were conducted in two maternity hospitals of Kabul City, Malali Maternity Hospital and Rabi Balkhi Hospital, and aimed at increasing the knowledge of preventive measures, early detection, treatment, palliative care and self-examinations of breast cancer among health workers of the hospitals. Another campaign was conducted among female students of Ghalib University, Dawat University and Khatam-Al-Nabieen University to inform and promote women’s involvement in breast cancer control activities. The aim was also to raise awareness regarding breast cancer through educating, empowering and persuading women and their community to make self-breast checks.


Take action

Join the Global NET Community on NET Cancer Day 2022 with a Wealth of INCA Campaign Materials in 10 Languages

GenMsg-01EN-Lscp-NETsarestill (002).jpeg

Created by the International Neuroendocrine Cancer Alliance (INCA) over 10 years ago, NET Cancer Day is held on November 10th to increase awareness of neuroendocrine (NET) cancers and to provide a voice to the NET community, asking for improved diagnostics, treatments, information, care and research. The campaign has grown exponentially since its inception, culminating with over 25 million impressions online last year.

The message this year is clear: Know the Symptoms, Push for Diagnosis – because patients worldwide are STILL struggling with a timely diagnosis.

We ask all our members and supporters to participate in the NET Cancer Day Campaign on November 10th. Let’s make a difference together.

Check out the dedicated NET Cancer Day 2022 section of the INCA website for the campaign social media tiles in 10 languages, patient stories from around the world, custom poster builder and a toolkit to help you navigate your campaign.

The World Cancer Day 2023 campaign official kick-off


On November 2, we kicked-off the second year of the #CloseTheCareGap campaign! Your involvement and ongoing support are what make World Cancer Day special. You’ve proven again and again that when we all rally behind this important cause—a cancer-free world—we can achieve amazing things.

Get the inside edge on what’s coming and get answers to your questions by joining our global member and partner calls. It's easy to join: simply register for the call of your choice by clicking the links below.



Women’s cancer in francophone Africa report workshop - Rapport sur le Dialogue régional sur les cancers féminins en Afrique francophone


UICC organised this summer a Regional Dialogue to support the work of governments and civil society to improve the prevention and treatment of women’s cancers in Francophone Africa, with over 60 participants from 12 French-speaking African countries.

L’UICC a organisé cet été un Dialogue régional afin de soutenir le travail des gouvernements et de la société civile pour promouvoir la prévention et le traitement des cancers féminins en Afrique francophone, avec la participation de plus de 60 personnes en provenance de 12 pays africains francophones.  

Updated Hard-to-Reach ABC/mBC Communities Toolkit


The Hard-to-Reach ABC/mBC Communities toolkit was developed by the ABC Global Alliance and Pfizer Oncology in 2021 to drive collaboration across the global ABC/mBC community and address the challenges for UPPs with ABC/mBC that were identified during an expert meeting of healthcare professionals, patient representatives, policymakers and politicians in October 2019.

Following the initial success of the toolkit, an additional 15 initiatives have been added to further address the unmet need for these hard-to-reach populations.

The Initiative Repository contains information on all initiatives included in the toolkit, grouped into four categories: Educating Patients & HCPs About ABC/mBC, Support for Patients with ABC/mBC, Peer-to-Peer Support Groups or Platforms for Patients with ABC/mBC and Raising Awareness & Promoting Earlier Diagnosis.

It also includes the contact details of initiative owners, and allows users to filter and short different criteria to find those that are most relevant. One-page summaries of each initiative can be accessed directly from the updated repository.


Training opportunities & calls for applications

Call for applications: CRUK's International Prevention Advisory Group

Cancer Research UK are looking for members for their new International Cancer Prevention Advisory Group to provide advice and input into their International Cancer Prevention (ICP) programme and to help steer the ongoing development of their global policy work. 

The ICP Programme aims to reduce the cancer burden in LMICs through cost-effective, affordable and preventative population-level interventions and the objectives are: 

  • At a national level: To support the generation and dissemination of policy- relevant research, promoting the implementation of effective preventative policies for tobacco control and cervical cancer in LMICs. 
  • At the global level: To advocate for implementation of WHO frameworks, strategies and treaties to prevent and address the growing burden of cancer in LMICs; and to build CRUK's voice as a leader on global cancer prevention.

CRUK are looking to establish a multi-disciplinary International Cancer Prevention Advisory Group (IPAG) to support these aims by:

  • Providing advice on the ICP Programmes strategic direction, informed by knowledge of current global health and international development trends;
  • Providing insights into possible connections/synergies across the portfolio and the wider global health sector;
  • Reviewing funding proposals: act as the expert review panel for the assessment of funding applications, including but not limited to commissioned policy research, partnership proposals and policy research and advocacy grants.

Please see the terms of reference for IPAG. The closing date to submit applications is November 28, 2022.

2022 Canadian Global Oncology Workshop

2022 Canadian Global Oncology Workshop EN (PNG).png

We are pleased to announce that registration for the 2022 Canadian Global Oncology Workshop on December 1st and 2nd, 2022 are open! The Canadian Global Oncology Workshop was designed to create an opportunity for leaders in oncology and global health to share ideas, experiences, and lessons learned in the field. Hosted by the McGill Global Oncology Program and Canadian Global Cancer Network, this free event is intended to foster collaboration and dialogue on initiatives in research, education, advocacy, and policy across the cancer care continuum, and to identify opportunities for pan-Canadian action in the field.

For information including registration, speakers, and sessions, interested attendees can visit the workshop website:

Letters of Intent now open for BIG Cat (Beginning Investigator Grant for Catalytic Research)! 


An African Organisation for Research and Training in Cancer (AORTIC) Program. Administered by AACR and in coordination with the U.S. National Cancer Institute Center for Global Health (NCI/CGH) and supported by Takeda Pharmaceuticals.

Please read the Program Guidelines and Competitive Letter of Intent Instructions carefully before submitting a Letter of Intent.

Final determinations of eligibility will not be made until the AACR is in receipt of the fully submitted Letter of Intent.

The research proposed for funding may be in any area of cancer research, including basic research, clinical research, population-based research and translational research across the cancer care continuum (prevention, early detection, diagnosis, treatment, supportive and palliative care, and survivorship).

Letter of Intent Deadline: 7 September 2022 5:00 PM (UTC)

Letter of Intent Notification Date:  October 2022

Application Deadline: 13 December 2022 5:00 PM (UTC)

Decision Date:  February 2023

Grant Term:  2 years

Start of Grant Term:  1 July 2023

Grant Amount:  $55,000 USD

5th Annual Combined Gulf Cancer Conference (CGCC)

In partnership with The Gulf Federation for Cancer Control and Gulf Center for Cancer Control & Prevention, Friends of Cancer Patients (FOCP), a member of UICC, is hosting the 5th Annual Combined Gulf Cancer Conference (CGCC) dedicated to the “Continuum of Care in Cancer Control & Management”. The Conference is scheduled on November 21-23, 2022 at Al Jawaher Reception and Convention Centre (JRCC) Sharjah, United Arab Emirates.

The scientific conference will address the care spectrum for Cancer in the Gulf Region, help analyse the current situation and highlight the best practices to move forward in order to improve the standard of care across the continuum of cancer control. Addressing all these topics and more, this conference will host different prominent international speakers, scientists and researchers.


Basavatarakam Indo American Cancer Hospital & Research Institute


Basavatarakam Indo-American Cancer Hospital & Research Institute is a leading cancer centre in India, consistently ranked among the Top 10 cancer hospitals in the country. Since its inception two decades ago, the hospital has grown exponentially to the current 650 bed facility with state-of-the-art operation rooms, intensive care units and round-the-clock critical care management.

The institution runs a coveted super-speciality training program in medical, surgical and radiation oncology alongside numerous fellowship modules in niche areas. Under the guidance of the Medical Director, Dr. Thammineedi Subramanyeshwar Rao, there is a vigorous emphasis on evidence-based cancer treatment through multi-disciplinary tumour boards and inter-departmental collaboration.

The establishment is run by a Board of Trustees headed by Shri. Nandamuri Balakrishna as a not-for-profit organisation, allowing the hospital to offer a wide range of comprehensive cancer therapy to deserving patients of all socio-economic strata.

The Synergist - From Testing to Targeted Treatment Program (FT3)


From Testing to Targeted Treatments (FT3) is a global multi-stakeholder programme making precision medicine a reality for all patients who can benefit from it.

The programme is a global catalyst identifying and sharing translatable good practices & learnings. FT3 brings together diverse stakeholders and activities in precision medicine to identify shared needs, build on existing good practices and learnings and make them replicable through practical and actionable tools and resources for precision medicine champions to drive real change and impact, starting with cancer and testing.

The Goal: accelerate the benefits of precision medicine by generating better evidence, creating awareness and building the conditions for better access to targeted medicine in oncology and beyond. 

Find out more about FT3 here. And discover more about the precision medicine landscape here

Ligue Nigérienne de Lutte contre le Cancer (LNLC)


La Ligue Nigérienne de Lutte contre le Cancer (LNLC) is a Non-governmental Organisation, recognised in Niger since June 8th, 2020.

It was founded by a former cancer patient, Mr Ibrahima Madougou Moubarak. The objectives of LNLC are:

  • Cancer prevention and screening;
  • Facilitate greater access to care;
  • Promote training and research in oncology;
  • Promote palliative care.

Since its creation, la Ligue Nigérienne de Lutte contre le Cancer has focused on four types of cancers: Breast Cancer, Cervical Cancer, Leukemia and Prostate Cancer.

The main areas of intervention of the NLCL is prevention. NLCL's slogan is: "Détecter Tôt le Cancer se Guérit", which means "Early detection cures cancer".

Finally, the NLCL aims to implement new approaches and strategies to fight cancer in Niger in order to achieve the objectives of the World Health Organisation (WHO). 

Last update: 
Friday 25 November 2022